358570 — GI Innovation Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	—	-75,933	-150,742	-79,833	-55,022
Depreciation
Amortisation
Non-Cash Items	-16,588	55,417	124,778	17,471	8,927
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	164	4,156	-2,761	-3,345	1,592
Change in Accounts Receivable
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-16,424	-15,182	-26,577	-62,550	-41,174
Capital Expenditures	-1,338	-3,213	-4,922	-2,970	-579
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-21,846	-8,121	-134,249	65,954	22,842
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-23,184	-11,334	-139,171	62,984	22,263
Financing Cash Flow Items	37,500	30,700	-62.5	—	-801
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	37,236	31,435	161,492	-32.1	25,109
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,372	4,919	-4,256	402	6,198